Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Neurotech Shareholders Back All AGM Resolutions

NTI: $0.017 +6.25% · MC: $31M

Neurotech International shareholders passed all resolutions put to a poll at the annual meeting, including director elections, placement-related approvals and options issues. The company’s latest quarterly update said its pivotal Phase 3 autism trial had begun dosing and it had secured funding intended to support development through the trial’s top-line results.

Source announcements: 2026-11-05 11:39 to 2026-11-05 11:39 Sydney time
Story updated 2026-11-05 11:41 Sydney time
SourcesResults of Meeting
Comments